France-based Sanofi and Britain’s GSK have announced on Friday that their coronavirus vaccines will face a delay and will be available until the end of 2021 after temporary results had shown a low immune response in older people.
The announcement from the companies is a huge setback in efforts to tackle the COVID-19 pandemic.
The companies said the delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme was to “improve immune response in older adults.”
The vaccine’s potential availability had been pushed back “from mid-2021 to Q4 2021,” they said in a statement.
Meanwhile, American pharmaceutical giant Pfizer and its German partner BioNTech have said their vaccine had proven 90 percent effectiveness in curtailing coronavirus infections in ongoing Phase 3 trials involving more than 40,000 people.
On Thursday, US experts voted to recommend granting emergency approval for the Pfizer-BioNTech vaccine, the move will pave the way for America to become the next country to go ahead with mass immunisation after the UK. Canada, Bahrain, and Saudi Arabia.
A minor earthquake struck in Karachi's Malir District on Wednesday evening. According to the National…
US President Joe Biden is reported to have signed four bills that also included a…
The United States has once again threatened Pakistan with imposing sanctions for signing new agreements…
Mohammad Rizwan and Irfan Khan have been ruled out of the last two T20Is against…
Hiba Bukhari and Danish Taimoor have been paired up again after 4 years for Geo…
A first look at 'Zard Patton Ka Bunn' starring Sajal Aly and Hamza Sohail leaves…